European Council adopts common position on FP7

Seventh Framework ProgrammeThe European Council adopted a common position on the Seventh Framework Programme (FP7) at a Competitiveness Council meeting, held on 25 September in Brussels. Agreement on FP7 should now be reached under the co-decision procedure, assuming the European Parliament responds positively in its second reading.

The political decision was made on 24 July during the previous Competitiveness Council, also held in Brussels. In the July meeting, all but the Austrian, Lithuanian, Maltese, Polish and Slovak delegations voted in favour, carrying FP7 through by a substantial qualified majority.

The political agreement came thanks to intervention by the Presidency, where rules for stem cell research were clarified, to the satisfaction of most delegations.

FP7 has been drawn up to give priority to four specific areas:

  • Cooperation - collaborative research;
  • Ideas - including the establishment of the European Research Council (ERC);
  • People - human resources;
  • Capacities.

FP7 is expected to be easier to negotiate for participants, offer more opportunities for research and researchers, and bring science and society closer.

FP7, including Euratom, has a budget of €50.4 billion.

For further information, please read Council Conclusions (.pdf file, 240.54 KB).

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Novartis and Microsoft Announce Collabor…

Novartis announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selecting Microsoft as its strategic AI and data-science partner for this effort. The...

Bayer Inks Deals with Eleven Startups un…

Bayer announced today that the company has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these startup companies aiming for longer-term collaborations...

Almirall Takes a Leap into Dermatology D…

Almirall, S.A. (ALM) has launched its first call for innovation to start-ups focused on dermatology digital health. This initiative is the first step in the creation of an accelerator programme...

Guerbet and IBM Watson Health Announce a…

Guerbet, a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, announced that it has signed a new agreement with IBM Watson Health to co-develop and...

Health Tech Marketing and PR Agency Incr…

Highland Marketing, a full service agency for health techmarketing, PR and communications, has appointed Tia Dissanayake to a new account executive role,in which she will support the team withher life...

Up-Close and Personal with Neuronal Netw…

How our brain cells, or neurons, use electrical signals to communicate and coordinate for higher brain function is one of the biggest questions in all of science. For decades, researchers...

Patients Say Ask before Using Medical Re…

With electronic medical records creating an ideal source of data to inform quality care and new discovery, a key question emerges: How much say should patients have in how their...

Secret-Shopper-Style Study Shows Online …

Web-based and digital-app services that offer oral contraception appear to be overall safe and efficient, according to the findings of a secret-shopper-style study conducted by researchers at Harvard Medical School...

Virtual Medical Visits Get Wary Welcome …

The technology is there. The funding is nearly there. The health providers are getting there. But a new US poll suggests that people over 50 aren't quite ready to fully...

Philips and Spencer Health Solutions Exp…

Building on their successful partnership providing medication adherence solutions to high-acuity patients in the U.S. Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and Spencer Health Solutions announced...